iPath S&P 500 Dynamic VIX ETN (XVZ) is an exchange-traded note issued by Barclays Bank PLC that provides exposure to forward implied volatility derived from the S&P 500 Dynamic VIX Futures Total Return Index; the index dynamically allocates between the S&P 500 VIX Short-Term Futures Index Excess Return and the S&P 500 VIX Mid-Term Futures Index Excess Return based on the steepness of the implied volatility curve, reflecting outcomes of holding long and at times long and short positions in futures contracts on the CBOE Volatility Index (VIX). Barclays Bank PLC serves as the issuer and counterparty for the unsecured senior debt obligation represented by the ETN, which targets investors seeking volatility hedging or speculation tied to U.S. large-cap equity market volatility; the product offers no dividends and relies on the daily indicative value for performance tracking. Originally launched on August 17, 2011, and listed on NYSE Arca, the ETN was scheduled to mature on August 18, 2021, with provisions for early holder redemption (minimum 50,000 units subject to a 0.05% fee) or issuer call at Barclays' discretion. Headquartered in London, United Kingdom, Barclays operates the iPath ETN platform globally, primarily serving institutional and retail investors in the United States through major exchanges.
In recent years, Barclays has undertaken significant strategic changes to its iPath ETN portfolio, including multiple issuer call redemptions of various series amid ongoing regulatory engagements with the U.S. Securities and Exchange Commission (SEC) over past over-issuance issues; for instance, in June 2025, Barclays announced and executed the full redemption of four iPath ETN series following cash tender offers and consent solicitations that amended indentures to enable discretionary early calls. Similar redemption actions occurred in December 2022 for six series and throughout 2024-2025 for additional ETNs, reflecting a broader wind-down of legacy volatility and commodity-linked products; no specific redemption or relaunch of XVZ has been publicly detailed in 2025 announcements, though it remains referenced in trading platforms amid Barclays' portfolio rationalization efforts. These moves align with Barclays' response to evidentiary challenges in ETN issuances and heightened regulatory scrutiny, prioritizing active series while phasing out underperforming or matured notes without new product launches or partnerships explicitly tied to the Dynamic VIX strategy.